Drug development Archives

In Depth 7 Jun 2021

The Post-Covid Future of AI for Drug Development

With the global Covid-19 outbreak in early 2020, pharma companies and biotechs have increasingly turned to artificial intelligence to improve precision and speed in drug development. Artificial intelligence (AI), the ability of machines to learn from new input, is a broad term for a range of computing methods. Recommendation engines used by online shopping or […]

June 7, 2021 - 11 minutesmins - By Matthew Williams

Opinion 19 Apr 2021

The Hidden Costs of Mismanaged R&D Projects in Biotech and Pharma

Mismanagement of R&D projects in biotech and pharma is more common than one might think and can result in high development costs and eventual clinical failure. Can we do something about it? Biotechnology and pharmaceutical businesses are synonymous with both a high risk and an even bigger investment. Bringing new drugs to the market can […]

April 19, 2021 - 7 minutesmins - By Auste Kanapeckaite

In Depth 22 Jul 2020

Artificial Intelligence: A Superpower in the Fight Against Covid-19

The rapid spread of Covid-19 around the world has left drug developers with limited time to identify drug candidates to fight the virus. Amid this crisis, artificial intelligence has proven its value as a tool to make drug discovery faster and cost-effective. Drug discovery is an expensive, long-winded process. Taking a drug from discovery to […]

July 22, 2020 - 8 minutesmins - By David Kirk

Why Biotechs Should Invest in Good Outsourcing Management of CROs

The relationship between biotechs and their CRO partners has been long in the making. These days, a collaboration with CROs is seen as a standard in the drug development industry. However, the management of drug development partners and providers can be highly challenging for biotechs. This is where outsourcing expertise can make the difference between […]

June 8, 2020 - 8 minutesmins - By External Contributor

How to Address the Challenges of Biologics Discovery and Development

The biologics industry is growing at an incredible rate. While its global market value was estimated at $236B in 2017, it is expected to rise to $310B by 2023. As key market players enter the field, competition is increasing. In recent years, the biologics industry has become more versatile and has moved from being primarily […]

November 27, 2019 - 6 minutesmins - By External Contributor

Resources

Categories

Swiss biotech going strong in 2024: 18 companies to put on your radar

The ABC of biotech startup funding

Approaches

Therapeutic areas

Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR

Special Olympics: How is biotechnology revolutionizing sports performance worldwide?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us